CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Indinavir Increases Midazolam N-Glucuronidation in Humans: Identification of an Alternate CYP3A Inhibitor Using an In Vitro to In Vivo Approach
Authors
Emily J Cox
Michael B Fisher
+6 more
Kosea S Frederick
Vanessa González-Pérez
Cathrine Leonowens
Mary F Paine
Yolanda V Scarlett
Dan-Dan Tian
Publication date
1 July 2019
Publisher
Providence St. Joseph Health Digital Commons
Abstract
Midazolam is a widely used index substrate for assessing effects of xenobiotics on CYP3A activity. A previous study involving human hepatocytes showed the primary route of midazolam metabolism, 1\u27-hydroxylation, shifted t
Similar works
Full text
Available Versions
Providence St. Joseph Health Digital Commons
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:digitalcommons.providence....
Last time updated on 17/10/2023